Balasa Dinverno & Foltz’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $5.06M | Buy |
53,033
+1,266
| +2% | +$121K | 0.32% | 34 |
|
|
2022
Q2 | $4.8M | Sell |
51,767
-5,372
| -9% | -$498K | 0.3% | 36 |
|
|
2022
Q1 | $5.78M | Buy |
57,139
+2,855
| +5% | +$289K | 0.39% | 28 |
|
|
2021
Q4 | $5.6M | Buy |
54,284
+1,785
| +3% | +$184K | 0.36% | 34 |
|
|
2021
Q3 | $4.46M | Buy |
52,499
+3,460
| +7% | +$294K | 0.31% | 34 |
|
|
2021
Q2 | $4.09M | Buy |
49,039
+1,240
| +3% | +$103K | 0.29% | 33 |
|
|
2021
Q1 | $3.6M | Buy |
47,799
+1,375
| +3% | +$103K | 0.29% | 34 |
|
|
2020
Q4 | $3.17M | Sell |
46,424
-11,098
| -19% | -$758K | 0.26% | 37 |
|
|
2020
Q3 | $3.36M | Buy |
57,522
+30,335
| +112% | +$1.77M | 0.32% | 32 |
|
|
2020
Q2 | $1.77M | Buy |
27,187
+9,906
| +57% | +$643K | 0.2% | 48 |
|
|
2020
Q1 | $1.03M | Buy |
17,281
+4,135
| +31% | +$245K | 0.13% | 82 |
|
|
2019
Q4 | $977K | Buy |
13,146
+5,636
| +75% | +$419K | 0.1% | 98 |
|
|
2019
Q3 | $474K | Buy |
7,510
+2,943
| +64% | +$186K | 0.05% | 156 |
|
|
2019
Q2 | $249K | Sell |
4,567
-1,062
| -19% | -$57.9K | 0.03% | 209 |
|
|
2019
Q1 | $304K | Sell |
5,629
-4,269
| -43% | -$231K | 0.04% | 185 |
|
|
2018
Q4 | $649K | Buy |
9,898
+2,307
| +30% | +$151K | 0.08% | 105 |
|
|
2018
Q3 | $598K | Buy |
7,591
+1,266
| +20% | +$99.7K | 0.07% | 118 |
|
|
2018
Q2 | $407K | Sell |
6,325
-1,000
| -14% | -$64.3K | 0.06% | 146 |
|
|
2018
Q1 | $456K | Buy |
7,325
+34
| +0.5% | +$2.12K | 0.07% | 127 |
|
|
2017
Q4 | $529K | Sell |
7,291
-517
| -7% | -$37.5K | 0.08% | 111 |
|
|
2017
Q3 | $635K | Buy |
7,808
+425
| +6% | +$34.6K | 0.1% | 90 |
|
|
2017
Q2 | $594K | Sell |
7,383
-131
| -2% | -$10.5K | 0.1% | 91 |
|
|
2017
Q1 | $590K | Buy |
7,514
+217
| +3% | +$17K | 0.1% | 84 |
|
|
2016
Q4 | $576K | Sell |
7,297
-43
| -0.6% | -$3.39K | 0.1% | 82 |
|
|
2016
Q3 | $653K | Sell |
7,340
-61
| -0.8% | -$5.43K | 0.12% | 71 |
|
|
2016
Q2 | $709K | Sell |
7,401
-165
| -2% | -$15.8K | 0.13% | 64 |
|
|
2016
Q1 | $785K | Sell |
7,566
-317
| -4% | -$32.9K | 0.14% | 53 |
|
|
2015
Q4 | $771K | Sell |
7,883
-357
| -4% | -$34.9K | 0.13% | 58 |
|
|
2015
Q3 | $795K | Buy |
8,240
+419
| +5% | +$40.4K | 0.14% | 55 |
|
|
2015
Q2 | $820K | Sell |
7,821
-5
| -0.1% | -$524 | 0.13% | 50 |
|
|
2015
Q1 | $808K | Buy |
7,826
+157
| +2% | +$16.2K | 0.12% | 54 |
|
|
2014
Q4 | $739K | Buy |
7,669
+243
| +3% | +$23.4K | 0.11% | 63 |
|
|
2014
Q3 | $591K | Sell |
7,426
-11
| -0.1% | -$875 | 0.09% | 75 |
|
|
2014
Q2 | $561K | Buy |
7,437
+172
| +2% | +$13K | 0.06% | 69 |
|
|
2014
Q1 | $544K | Buy |
7,265
+799
| +12% | +$59.8K | 0.07% | 69 |
|
|
2013
Q4 | $463K | Buy |
6,466
+63
| +1% | +$4.51K | 0.06% | 75 |
|
|
2013
Q3 | $363K | Buy |
6,403
+60
| +0.9% | +$3.4K | 0.06% | 83 |
|
|
2013
Q2 | $363K | Buy |
+6,343
| New | +$363K | 0.06% | 80 |
|